Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Eye movement desensitization and reprocessing (EMDR) therapy or supportive counseling prior to exposure therapy in patients with panic disorder: study protocol for a multicenter randomized controlled trial (IMPROVE).
Endhoven B, De Cort K, Matthijssen SJMA, de Jongh A, van Minnen A, Duits P, Schruers KRJ, van Dis EAM, Krypotos AM, Gerritsen L, Engelhard IM. Endhoven B, et al. Among authors: duits p. BMC Psychiatry. 2023 Mar 14;23(1):157. doi: 10.1186/s12888-022-04320-4. BMC Psychiatry. 2023. PMID: 36918861 Free PMC article.
No Effects of D-Cycloserine Enhancement in Exposure With Response Prevention Therapy in Panic Disorder With Agoraphobia: A Double-Blind, Randomized Controlled Trial.
Hofmeijer-Sevink MK, Duits P, Rijkeboer MM, Hoogendoorn AW, van Megen HJ, Vulink NC, Denys DA, van den Hout MA, van Balkom AJ, Cath DC. Hofmeijer-Sevink MK, et al. Among authors: duits p. J Clin Psychopharmacol. 2017 Oct;37(5):531-539. doi: 10.1097/JCP.0000000000000757. J Clin Psychopharmacol. 2017. PMID: 28820746 Clinical Trial.
Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic disorder with agoraphobia: A randomised controlled trial.
Kwee CM, Baas JM, van der Flier FE, Groenink L, Duits P, Eikelenboom M, van der Veen DC, Moerbeek M, Batelaan NM, van Balkom AJ, Cath DC. Kwee CM, et al. Among authors: duits p. Eur Neuropsychopharmacol. 2022 Jun;59:58-67. doi: 10.1016/j.euroneuro.2022.04.003. Epub 2022 May 10. Eur Neuropsychopharmacol. 2022. PMID: 35561538 Free article. Clinical Trial.
11 results